Company Filing History:
Years Active: 2006-2013
Title: Han-Mou Tsai: Innovator in ADAMTS Protease Research
Introduction
Han-Mou Tsai is a distinguished inventor based in Manhasset, NY (US). He has made significant contributions to the field of biochemistry, particularly in the study of disintegrins and metalloproteinases. With a total of 5 patents, his work has advanced the understanding and application of ADAMTS proteases.
Latest Patents
His latest patents focus on a novel ADAMTS13 protease and the nucleic acids encoding these proteases. The inventions encompass both native and recombinant wild-type forms of ADAMTS13, as well as mutant and variant forms, including fragments that exhibit altered characteristics compared to the wild-type ADAMTS13. These inventions also relate to methods for using ADAMTS13 in the treatment of Thrombotic Thrombocytopenic Purpura (TTP), screening for the presence of TTP, and developing anticoagulant drugs based on ADAMTS13.
Career Highlights
Han-Mou Tsai is affiliated with the University of Michigan, where he continues to engage in groundbreaking research. His work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.
Collaborations
He has collaborated with notable colleagues, including David Ginsburg and Gallia Levy, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Han-Mou Tsai's innovative work in the field of ADAMTS proteases exemplifies the importance of research in advancing medical science. His contributions are vital for the development of new treatments and understanding of complex biological processes.